DOSSIER · 13F Holders · Q2 2026
ELOX
ELOXX PHARMACEUTICALS INC
21 institutions still hold ELOXX PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 29014R301·21 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
21 institutions reported ELOX in Q2 2026. Nantahala Capital Management, LLC leads at 32.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
1 more holders available. Log in →